These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5570964)

  • 1. Prolonged toxicity studies with -(4-methylpiperidino)-p-fluorobutyrophenone, a new neuroleptic agent.
    Harper KH; Noel PR
    Toxicol Appl Pharmacol; 1971 Jun; 19(2):127-33. PubMed ID: 5570964
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological and toxicological studies on gamma-(4-methylpiperidino)-p-fluorobutyrophenone (FG 5111)--a new neuroleptic agent.
    Christensen JA; Hernestam S; Lassen JB; Sterner N
    Acta Pharmacol Toxicol (Copenh); 1965; 23(2):109-32. PubMed ID: 5899275
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged toxicological studies in the rat and beagle dog with methylperone hydrochloride, with embryo toxicity studies in the rabbit and rat.
    Heywood R; Palmer AK
    Farmaco Prat; 1974 Oct; 29(10):586-93. PubMed ID: 4422950
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; Van Nueten JM; Schaper WK
    Eur J Pharmacol; 1970 Jul; 11(2):139-54. PubMed ID: 5447800
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; van Nueten JM; Marsboom RH; Hérin VV; Schaper WK
    Arzneimittelforschung; 1970 Nov; 20(11):1689-98. PubMed ID: 4992598
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiac toxicity of antidepressive agents].
    Schaefer J
    Dtsch Med Wochenschr; 1973 Sep; 98(36):1683. PubMed ID: 4147461
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of basic metabolites of 4-[4-(p-chlo- robenzoyl)piperidino]-4'-fluorobutyrophenone, an experimental neuroleptic agent.
    Fusaro GA; Garteiz DA; Chan KY; Leeson GA
    Drug Metab Dispos; 1976; 4(6):562-7. PubMed ID: 11978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
    Castaigne P; Lapresle J; Chain F
    Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
    [No Abstract]   [Full Text] [Related]  

  • 10. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicologic studies of glycopyrrolate in combination with other drugs.
    Franko BV; Ward JW; Gilbert DL; Woodard G
    Toxicol Appl Pharmacol; 1971 May; 19(1):93-102. PubMed ID: 4398301
    [No Abstract]   [Full Text] [Related]  

  • 12. [Iatrogenic facial dyskinesia].
    Joosen E; Wackens G
    Acta Stomatol Belg; 1974; 71(3):321-4. PubMed ID: 4155240
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of so-called late dyskinetic syndrome appearing early during neuroleptic treatment].
    Sizaret P; Degiovanni A
    Ann Med Psychol (Paris); 1974 Feb; 1(2):247-9. PubMed ID: 4858843
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of long-term administration of oxyprothepin on reflexes in dogs.
    Sýkora I
    Act Nerv Super (Praha); 1974 Mar; 16(1):6-9. PubMed ID: 4454944
    [No Abstract]   [Full Text] [Related]  

  • 16. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
    Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 6-hydroxydopamine on body weight: feeding deficits or sensory-motor impairments?
    Pelham RW; Lippa AS; Sano MC
    Commun Psychopharmacol; 1977; 1(6):553-63. PubMed ID: 608325
    [No Abstract]   [Full Text] [Related]  

  • 18. Tranquilizing drugs. Carbamates of 4-(4-hydroxypiperidino)-4'-fluorobutyrophenone and analogs.
    Li JP; Stein RG; Biel JH; Gylys JA; Ridlon SA
    J Med Chem; 1970 Nov; 13(6):1230-2. PubMed ID: 5479876
    [No Abstract]   [Full Text] [Related]  

  • 19. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
    Denber HC
    Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?
    Janssen PA; Niemegeers CJ; Schellekens KH
    Arzneimittelforschung; 1966 Mar; 16(3):339-46. PubMed ID: 6013843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.